LivaNova (LIVN) Profit After Tax Growth (3y) (Quarter) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 44.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.62% |
| Dec 31, 2025 | 164.99% |
| Sep 30, 2025 | 31.03% |
| Jun 30, 2025 | 18.21% |
| Mar 31, 2025 | -381.11% |
| Dec 31, 2024 | 134.54% |
| Sep 30, 2024 | 40.25% |
| Jun 30, 2024 | 31.79% |
| Mar 31, 2024 | -10.89% |
| Dec 31, 2023 | 27.20% |
| Sep 30, 2023 | 20.95% |
| Jun 30, 2023 | 26.26% |
| Mar 31, 2023 | -41.84% |
| Dec 31, 2022 | 26.23% |
| Sep 30, 2022 | -74.81% |
| Jun 30, 2022 | 36.85% |
| Mar 31, 2022 | 30.09% |
| Dec 31, 2021 | 70.97% |
| Sep 30, 2021 | -90.61% |
| Jun 30, 2021 | -79.15% |
| Mar 31, 2021 | -55.03% |
| Dec 31, 2020 | -107.38% |
| Sep 30, 2020 | -36.30% |
| Jun 30, 2020 | -58.18% |
| Mar 31, 2020 | 49.23% |
| Dec 31, 2019 | -183.32% |
| Sep 30, 2019 | 182.19% |
| Jun 30, 2019 | -62.53% |
| Mar 31, 2019 | 28.36% |
| Dec 31, 2017 | -110.68% |